Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+39.4%
5Y CAGR+48.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+39.4%/yr
vs +33.6%/yr prior
5Y CAGR
+48.4%/yr
Recent deceleration
Acceleration
+5.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
7.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $95.31M | +56.0% |
| 2024 | $61.08M | -35.7% |
| 2023 | $95.00M | +170.0% |
| 2022 | $35.18M | +36.3% |
| 2021 | $25.80M | +94.5% |
| 2020 | $13.27M | +13.9% |
| 2019 | $11.65M | +5.4% |
| 2018 | $11.05M | +1.3% |
| 2017 | $10.91M | +14.0% |
| 2016 | $9.57M | - |